These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11503630)

  • 1. Oral transmucosal fentanyl and sufentanil for incident pain.
    Gardner-Nix J
    J Pain Symptom Manage; 2001 Aug; 22(2):627-30. PubMed ID: 11503630
    [No Abstract]   [Full Text] [Related]  

  • 2. [What is the dosage recommendation for sufentanil and fentanyl?].
    Janson W; Kopf A
    Anaesthesist; 1999 Mar; 48(3):188-9. PubMed ID: 10234402
    [No Abstract]   [Full Text] [Related]  

  • 3. Oral transmucosal fentanyl citrate--OTFC (ACTIQ) #103.
    Gordon D; Schroeder M
    J Palliat Med; 2008 May; 11(4):633-4. PubMed ID: 18454617
    [No Abstract]   [Full Text] [Related]  

  • 4. Fentanyl nasal spray (Lazanda) for pain.
    Med Lett Drugs Ther; 2011 Dec; 53(1379-1380):99-100. PubMed ID: 22173454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcutaneous fentanyl and sufentanil infusion substitution for morphine intolerance in cancer pain management.
    Paix A; Coleman A; Lees J; Grigson J; Brooksbank M; Thorne D; Ashby M
    Pain; 1995 Nov; 63(2):263-269. PubMed ID: 8628593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of fentanyl sublingual spray for the treatment of breakthrough cancer pain: a randomized, double-blind, placebo-controlled study.
    Rauck R; Reynolds L; Geach J; Bull J; Stearns L; Scherlis M; Parikh N; Dillaha L
    Curr Med Res Opin; 2012 May; 28(5):859-70. PubMed ID: 22480131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transmucosal fentanyl in ovarian cancer.
    Loitman JE
    J Pain Symptom Manage; 2002 Jan; 23(1):5-7. PubMed ID: 11779661
    [No Abstract]   [Full Text] [Related]  

  • 8. Pilot dose finding study of intranasal sufentanil for breakthrough and incident cancer-associated pain.
    Jackson K; Ashby M; Keech J
    J Pain Symptom Manage; 2002 Jun; 23(6):450-2. PubMed ID: 12067765
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacologic management of adult breakthrough cancer pain.
    Doulton B
    Can Fam Physician; 2014 Dec; 60(12):1111-4, e585-9. PubMed ID: 25500600
    [No Abstract]   [Full Text] [Related]  

  • 10. Determination of the analgesic dose-response relationship for epidural fentanyl and sufentanil with bupivacaine 0.125% in laboring patients.
    Herman NL; Sheu KL; Van Decar TK; Rubin JD; Gadalla F; Koff HD; Reynolds JE
    J Clin Anesth; 1998 Dec; 10(8):670-7. PubMed ID: 9873970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fentanyl sublingual tablets. Breakthrough pain: new formulation, no therapeutic advantage.
    Prescrire Int; 2010 Feb; 19(105):16. PubMed ID: 20455334
    [No Abstract]   [Full Text] [Related]  

  • 12. A new transmucosal fentanyl for breakthrough cancer pain.
    Rospond RM
    Cancer Pract; 1999; 7(6):317-20. PubMed ID: 10732531
    [No Abstract]   [Full Text] [Related]  

  • 13. [Tumor pain. Fentanyl TTS: a transdermal system for tumor pain therapy].
    Dtsch Med Wochenschr; 1995 Oct; 120(41 Suppl):1-4. PubMed ID: 9022357
    [No Abstract]   [Full Text] [Related]  

  • 14. Oral transmucosal fentanyl: new preparation. For breakthrough cancer pain when morphine fails.
    Prescrire Int; 2002 Aug; 11(60):106-7. PubMed ID: 12199262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral transmucosal fentanyl citrate: a new treatment for breakthrough pain.
    Chandler S
    Am J Hosp Palliat Care; 1999; 16(2):489-91. PubMed ID: 10232127
    [No Abstract]   [Full Text] [Related]  

  • 16. Pain recurrence on the third day after application of a transdermal fentanyl patch.
    Konishi H; Ishihara C; Chiba M; Endo Y; Yamaji A
    Pharm World Sci; 2005 Aug; 27(4):353. PubMed ID: 16228637
    [No Abstract]   [Full Text] [Related]  

  • 17. Fentanyl buccal tablet (Fentora) for breakthrough pain.
    Med Lett Drugs Ther; 2007 Sep; 49(1270):78-9. PubMed ID: 17878889
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of pain-related behavior, bone destruction and effectiveness of fentanyl, sufentanil, and morphine in a murine model of cancer pain.
    El Mouedden M; Meert TF
    Pharmacol Biochem Behav; 2005 Sep; 82(1):109-19. PubMed ID: 16125759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of sublingual sufentanil for postoperative pain management.
    van de Donk T; Ward S; Langford R; Dahan A
    Anaesthesia; 2018 Feb; 73(2):231-237. PubMed ID: 29219169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral transmucosal fentanyl citrate: overview of pharmacological and clinical characteristics.
    Mystakidou K; Katsouda E; Parpa E; Vlahos L; Tsiatas ML
    Drug Deliv; 2006; 13(4):269-76. PubMed ID: 16766468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.